A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-14
DOI
10.1038/s41467-020-17962-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Next Generation Sequencing Revealed a Novel Homozygous Loss-of-Function Mutation in ILDR1 Gene Causes Autosomal Recessive Nonsyndromic Sensorineural Hearing Loss in a Chinese Family
- (2019) Jinxia An et al. Frontiers in Genetics
- CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
- (2019) Grégoire Cullot et al. Nature Communications
- Microhomologies are prevalent at Cas9-induced larger deletions
- (2019) Dominic D G Owens et al. NUCLEIC ACIDS RESEARCH
- The Chromatin Structure of CRISPR-Cas9 Target DNA Controls the Balance between Mutagenic and Homology-Directed Gene-Editing Events
- (2019) Josephine M. Janssen et al. Molecular Therapy-Nucleic Acids
- DNA-PK as an Emerging Therapeutic Target in Cancer
- (2019) Ismail S. Mohiuddin et al. Frontiers in Oncology
- Therapeutic implications of p53 status on cancer cell fate following exposure to ionizing radiation and the DNA-PK inhibitor M3814
- (2019) Qing Sun et al. MOLECULAR CANCER RESEARCH
- A solid‐phase transfection platform for arrayed CRISPR screens
- (2019) Özdemirhan Serçin et al. Molecular Systems Biology
- A novel and versatile dual fluorescent reporter tool for the study of gene expression and regulation in multi- and single copy number
- (2018) Indra Bervoets et al. GENE
- Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks
- (2018) Eva K. Brinkman et al. MOLECULAR CELL
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway
- (2018) Chris D. Richardson et al. NATURE GENETICS
- C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains
- (2018) Ragini Bhargava et al. Nature Communications
- Target-Specific Precision of CRISPR-Mediated Genome Editing
- (2018) Anob M. Chakrabarti et al. MOLECULAR CELL
- Predictable and precise template-free CRISPR editing of pathogenic variants
- (2018) Max W. Shen et al. NATURE
- Predicting the mutations generated by repair of Cas9-induced double-strand breaks
- (2018) Felicity Allen et al. NATURE BIOTECHNOLOGY
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- DNA Double-Strand Break Resection Occurs during Non-homologous End Joining in G1 but Is Distinct from Resection during Homologous Recombination
- (2017) Ronja Biehs et al. MOLECULAR CELL
- Non-homologous DNA end joining and alternative pathways to double-strand break repair
- (2017) Howard H. Y. Chang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- A Process of Resection-Dependent Nonhomologous End Joining Involving the Goddess Artemis
- (2017) Markus Löbrich et al. TRENDS IN BIOCHEMICAL SCIENCES
- In situ click chemistry generation of cyclooxygenase-2 inhibitors
- (2017) Atul Bhardwaj et al. Nature Communications
- Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
- (2017) Mary Glorieux et al. Oncotarget
- BRCA1 Directs the Repair Pathway to Homologous Recombination by Promoting 53BP1 Dephosphorylation
- (2017) Mayu Isono et al. Cell Reports
- The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/- lymphoblastoid cells
- (2017) Emma C. Bourton et al. Journal of Cancer
- Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
- (2016) Sébastien L. Degorce et al. JOURNAL OF MEDICINAL CHEMISTRY
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Chromatin determinants of the inner-centromere rely on replication factors with functions that impart cohesion
- (2016) Takuya Abe et al. Oncotarget
- GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing
- (2016) Astrid Glaser et al. Molecular Therapy-Nucleic Acids
- Functions of PARylation in DNA Damage Repair Pathways
- (2016) Huiting Wei et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
- (2015) T. A. Hopkins et al. MOLECULAR CANCER RESEARCH
- Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair
- (2015) Raphael Ceccaldi et al. NATURE
- Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
- (2015) Francis Robert et al. Genome Medicine
- 53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
- (2014) J. M. Daley et al. MOLECULAR AND CELLULAR BIOLOGY
- Understanding nucleotide excision repair and its roles in cancer and ageing
- (2014) Jurgen A. Marteijn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays
- (2014) Camilo Guzmán et al. PLoS One
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- (2014) Felix Dietlein et al. TRENDS IN GENETICS
- Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
- (2013) N J Curtin BRITISH JOURNAL OF PHARMACOLOGY
- Novel fluorescent genome editing reporters for monitoring DNA repair pathway utilization at endonuclease-induced breaks
- (2013) Ryan Kuhar et al. NUCLEIC ACIDS RESEARCH
- New Tools to Study DNA Double-Strand Break Repair Pathway Choice
- (2013) Daniel Gomez-Cabello et al. PLoS One
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- DNA Repair Inhibitors: The Next Major Step to Improve Cancer Therapy
- (2012) Khaled Barakat et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
- (2012) E Fokas et al. Cell Death & Disease
- Tracking genome engineering outcome at individual DNA breakpoints
- (2011) Michael T Certo et al. NATURE METHODS
- BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
- (2011) A. Aly et al. Journal of Molecular Cell Biology
- A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability
- (2010) K. E. Hurov et al. GENES & DEVELOPMENT
- Targeting homologous recombination repair defects in cancer
- (2010) Bastiaan Evers et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Homologous recombination in DNA repair and DNA damage tolerance
- (2008) Xuan Li et al. CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now